Skip to main content
MASI
NASDAQ Life Sciences

Masimo 补充合并代理声明以应对股东诉讼;交易条款未变

feedReported by Wiseek News
Sentiment info
Neutral
Importance info
7
Price
$178.55
Mkt Cap
$9.358B
52W Low
$125.94
52W High
$179
Market data snapshot near publication time

summarizeSummary

Masimo Corp宣布将自愿补充其与Danaher拟议合并相关的最终代理声明。这一决定是在多起股东诉讼和要求函件中提出初始代理声明不完整的指控之后做出的。虽然该公司否认这些指控,但补充的目的是为了减少诉讼风险并避免潜在的合并延迟。重要的是,每股合并对价和董事会对投票赞成合并的建议保持不变,表明核心交易结构不受影响。交易者应该监测这些法律挑战的解决和合并的进展,尽管该公司的主动措施表明其致力于完成交易。

在该公告发布时,MASI的交易价格为$178.55,交易所为NASDAQ,所属行业为Life Sciences,市值约为$93.6亿。 52周交易区间为$125.94至$179.00。 这则新闻被评估为中性市场情绪,重要性评分为7/10。 来源:Wiseek News。


show_chartPrice Chart

Share this article

Copied!

feed MASI - Latest Insights

MASI
Apr 23, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
7
MASI
Apr 23, 2026, 5:08 PM EDT
Filing Type: DEFA14A
Importance Score:
8
MASI
Apr 23, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
8
MASI
Apr 01, 2026, 9:31 AM EDT
Filing Type: DEFM14A
Importance Score:
9
MASI
Mar 18, 2026, 5:15 PM EDT
Filing Type: PREM14A
Importance Score:
9
MASI
Mar 13, 2026, 7:25 PM EDT
Filing Type: 4
Importance Score:
8
MASI
Feb 17, 2026, 9:45 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
MASI
Feb 17, 2026, 8:48 AM EST
Filing Type: DEFA14A
Importance Score:
9
MASI
Feb 17, 2026, 8:44 AM EST
Filing Type: 8-K
Importance Score:
10
MASI
Jan 12, 2026, 9:02 AM EST
Filing Type: 8-K
Importance Score:
7